SEC Filings for ImmunoGen Inc. (IMGN)

$ 4.92   0.24 (+5.13%) Volume: 2.58m 4:00 PM EDT 1-Jun-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities106/24/2019
8-KCurrent report pursuant to Section 13 or 15(d)306/24/2019
8-KCurrent report pursuant to Section 13 or 15(d)205/15/2019
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals105/09/2019
10-QGeneral form for quarterly reports under Section 13 or 15(d)4405/07/2019
8-KCurrent report pursuant to Section 13 or 15(d)705/03/2019
DEF 14AOther definitive proxy statements4404/30/2019
DEFA14AAdditional proxy soliciting materials - definitive504/30/2019
4Statement of changes in beneficial ownership of securities104/08/2019
4Statement of changes in beneficial ownership of securities104/01/2019
4Statement of changes in beneficial ownership of securities104/01/2019
CT ORDERConfidential treatment order103/19/2019
CT ORDERConfidential treatment order103/19/2019
10-KAnnual report pursuant to Section 13 or 15(d)17803/01/2019
8-KCurrent report pursuant to Section 13 or 15(d)403/01/2019
123456789101112131415